The assessment of autofluorescence of the crystalline lens in diabetic patients and healthy controls: Can it be used as a screening test?

dc.contributor.author	Pehlivanoğlu, S.
dc.contributor.author	Acar, N.
dc.contributor.author	Albayrak, S.
dc.contributor.author	Karakaya, M.
dc.contributor.author	Ofluoğlu, A.
dc.date.accessioned	2021-12-21T08:41:04Z
dc.date.available	2021-12-21T08:41:04Z
dc.date.issued	2018
dc.identifier.issn	11775467
dc.identifier.uri	https://doi.org/10.2147/OPTH.S164960
dc.identifier.uri	http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/1308
dc.description.abstract	Background: Our purpose was to demonstrate if measuring lens autofluorescence (AF) with a scanning confocal biomicroscope may be used to identify subjects with undiagnosed type II diabetes mellitus (DM), and hence, for it to be used as a marker for the se
dc.language.iso	English
dc.publisher	Dove Medical Press Ltd
dc.rights	All Open Access, Gold, Green
dc.title	The assessment of autofluorescence of the crystalline lens in diabetic patients and healthy controls: Can it be used as a screening test?
dc.type	Article
dc.relation.journal	Clinical Ophthalmology
dc.identifier.startpage	1163
dc.identifier.endpage	1170
dc.identifier.volume	12
dc.identifier.doi	10.2147/OPTH.S164960
dc.relation.volume	12

Bu öğenin dosyaları:

Dosyalar	Boyut	Biçim	Göster
Bu öğe ile ilişkili dosya yok.